Thermo Fisher’s Oncomine Dx Test Approved for Identifying Patients for VORANIGO® in IDH-Mutant Glioma

Oncomine Dx Target Test to Identify Patients Eligible for Servier’s VORANIGO® (vorasidenib) tablet, the only F...

October 22, 2024 | Tuesday | News
Eppendorf Research plus is the first pipette to receive My Green Lab ACT label

By emphasizing Accountability, Consistency, and Transparency (ACT) around manufacturing, energy and water use, packaging...

December 17, 2021 | Friday | News

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls